Skip to main content
Toggle navigation
Login
Search
Home
Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Poster Title
Home
Browse by Poster Title
Browse by Poster Title
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Sort by
#
Sort by
Title
Q
T-113
QSP model trained on preclinical data informs clinical dose selection for a T-cell engaging bispecific antibody for solid tumor indications
Favorite
W-058
QSP-based virtual twin approach provides mechanistic insight into enzyme replacement therapies in Pompe Disease
Favorite
T-126
Quantification of uncertainty in human dose predictions
Favorite
W-081
Quantifying dengue natural immunity and probability of disease using serum antibody titers
Favorite
M-010
Quantitative system pharmacology model for tri-specific HER2xCD3xCD28 T-Cell Engager SAR443216
Favorite
T-008
Quantitative Systems Pharmacology (QSP) model for combined targeting of BAFF and CD40 pathways in systemic lupus erythematosus
Favorite
W-060
Quantitative systems pharmacology model for distinguishing efficacy of anti-CD20 therapy variants in populations of Multiple Sclerosis patients
Favorite
T-077
Quantitative Systems Pharmacology Modeling of Loncastuximab Tesirine Combined with Mosunetuzumab and Glofitamab Helps Guide Dosing for Patients with DLBCL
Favorite
W-061
Quantitative systems pharmacology modeling of neurotoxicity and cognitive scores in Alzheimer’s disease for prediction of therapy outcomes
Favorite
W-120
Quantitative Systems Pharmacology Modeling of X-linked Hypophosphatemia Disease Pathway Normalization to Predict the Impact of Burosumab Treatment on Serum Biomarkers in Adult and Pediatric Patients
Favorite
W-096
Quantitative Systems Pharmacology of T-cell Engagers and Cytokine Release
Favorite
M-120
Quantitative Systems Toxicology Modeling of Otenaproxesul Liver Enzyme Elevations Leads to Prediction of Liver Safety for Acute Otenaproxesul Dosing
Favorite